Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: a) ASA I- II b) Scheduled to undergo elective modified radical mastectomy
Exclusion criteria
Exclusion criteria: a) Patient refusal for regional techniques b) All contra-indications to regional techniques: Local or systemic infection Known allergy to the study drugs Bleeding disorders Platelet count c) BMI > 35 d) Inability to use PCA device post operatively
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy of analgesic technique determined by 11-point numeric rating scale (NRS) at rest & on abduction of ipsilateral arm above the head.Timepoint: Post-operative period at 0, 0.5, 1, 2, 4, 6, 12 & 24 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| 24-hour fentanyl consumptionTimepoint: 1st 24 hours of post-operative period;Intraoperative opioid consumption.Timepoint: Intraoperative period; ? Incidence of adverse events (postoperative nausea/ vomiting, respiratory depression, pruritus, urinary retention) retention)Timepoint: 1st 24 hours of post-operative period.;Patient satisfaction scoreTimepoint: Post-operative period at 0, 0.5, 1, 2, 4, 6, 12 & 24 hours;Time to first analgesic requirement in post-operative period.Timepoint: 1st 24 hours of Post operative period | — |
Countries
India
Contacts
All India Institute of Medical Sciences